Login Register Cart 0
Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5230
ISSN (Online): 1875-614X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

C1 Inhibitor Administration Reduces Local Inflammation and Capillary Leakage, Without Affecting Long-term Wound Healing Parameters, in a Pig Burn Wound Model

Author(s): Halil Ibrahim Korkmaz*, Magda M.W. Ulrich, Wessel N. Van Wieringen, Hatice Doǧan, Marcel Vlig, Reindert W. Emmens, Klaas W. Meyer, Paul Sinnige, Sacha Zeerleder, Diana Wouters, Marieke S. Van Ham, Paul P.M. Van Zuijlen, Paul A.J. Krijnen and Hans W.M. Niessen

Volume 20, Issue 2, 2021

Published on: 02 July, 2020

Page: [150 - 160] Pages: 11

DOI: 10.2174/1871523019666200702101513

Price: $65

Abstract

Background: Burns induce a boost in local and systemic complement levels as well as immune cell infiltration in the burn wound, which may negatively affect wound healing.

Objective: In this study, the effects of long-term treatment with complement inhibitor C1 esterase inhibitor (C1inh) on post-burn inflammation and wound healing parameters were analyzed in time up to 60 days post-burn.

Methods: Burned pigs were treated either with or without C1inh up to 15 days post-burn. Burn wound biopsies and blood were collected at different time points up to 60 days post-burn. Thereafter, complement in blood as well as complement and immune cells in the wound, capillary leakage, necrosis, reepithelialization and wound contraction were quantified.

Results: No significant differences in complement C3 blood levels were observed at any time point between C1inh-treated and control pigs. In the wound, complement C4 levels were significantly lower in the C1inh group than in controls at day 3-6 and 21-30 post-burn. Similarly, C3 levels, neutrophil and macrophage infiltration in the wound were, although not statistically significant, reduced in C1inh-treated pigs at day 9-14 post-burn. No differences in lymphocyte infiltration in the wound were found between C1inh and control pigs. C1inh-treated pigs also showed reduced capillary leakage. Despite these effects, no significant differences in the long-term wound healing parameters necrosis, reepithelialization and wound contraction were observed between C1inh and control pigs.

Conclusion: In pigs, 15 days of C1inh treatment after burn, leads to a reduction in local inflammation and capillary leakage in the burn wound without affecting long-term wound healing parameters.

Keywords: C1 inhibitor, complement, inflammation, capillary leakage, burn wound, wound healing, pig burn wound model.

« Previous Next »
Graphical Abstract

[1]
Heideman, M.; Bengtsson, A. The immunologic response to thermal injury. World J. Surg., 1992, 16(1), 53-56.
[http://dx.doi.org/10.1007/BF02067115] [PMID: 1290267]
[2]
Gallinaro, R.; Cheadle, W.G.; Applegate, K.; Polk, H.C., Jr The role of the complement system in trauma and infection. Surg. Gynecol. Obstet., 1992, 174(5), 435-440.
[PMID: 1570624]
[3]
van de Goot, F.; Krijnen, P.A.; Begieneman, M.P.; Ulrich, M.M.; Middelkoop, E.; Niessen, H.W. Acute inflammation is persistent locally in burn wounds: A pivotal role for complement and C-reactive protein. J. Burn Care Res., 2009, 30(2), 274-280.
[http://dx.doi.org/10.1097/BCR.0b013e318198a252] [PMID: 19165117]
[4]
Ward, P.A.; Till, G.O. Pathophysiologic events related to thermal injury of skin. J. Trauma, 1990, 30(12)(Suppl.), S75-S79.
[http://dx.doi.org/10.1097/00005373-199012001-00018] [PMID: 2254996]
[5]
Wan, K.C.; Evans, J.H. Free radical involvement in hypertrophic scar formation. Free Radic. Biol. Med., 1999, 26(5-6), 603-608.
[http://dx.doi.org/10.1016/S0891-5849(98)00245-7] [PMID: 10218648]
[6]
Suber, F.; Carroll, M.C.; Moore, F.D., Jr Innate response to self-antigen significantly exacerbates burn wound depth. Proc. Natl. Acad. Sci. USA, 2007, 104(10), 3973-3977.
[http://dx.doi.org/10.1073/pnas.0609026104] [PMID: 17360462]
[7]
Barrett, M. The clinical value of acute phase reactant measurements in thermal injury. Scand. J. Plast. Reconstr. Surg. Hand Surg., 1987, 21(3), 293-295.
[PMID: 2450399]
[8]
Dhennin, Ch.; Pinon, G.; Greco, J.M. Alterations of complement system following thermal injury: Use in estimation of vital prognosis. J. Trauma, 1978, 18(2), 129-133.
[http://dx.doi.org/10.1097/00005373-197802000-00010] [PMID: 633421]
[9]
Gelfand, J.A.; Donelan, M.; Hawiger, A.; Burke, J.F. Alternative complement pathway activation increases mortality in a model of burn injury in mice. J. Clin. Invest., 1982, 70(6), 1170-1176.
[http://dx.doi.org/10.1172/JCI110715] [PMID: 7174787]
[10]
Henze, U.; Lennartz, A.; Hafemann, B.; Goldmann, C.; Kirkpatrick, C.J.; Klosterhalfen, B. The influence of the C1-inhibitor BERINERT and the protein-free haemodialysate ACTIHAEMYL20% on the evolution of the depth of scald burns in a porcine model. Burns, 1997, 23(6), 473-477.
[http://dx.doi.org/10.1016/S0305-4179(97)00019-3] [PMID: 9429024]
[11]
Radke, A.; Mottaghy, K.; Goldmann, C.; Khorram-Sefat, R.; Kovacs, B.; Janssen, A.; Klosterhalfen, B.; Hafemann, B.; Pallua, N.; Kirschfink, M. C1 inhibitor prevents capillary leakage after thermal trauma. Crit. Care Med., 2000, 28(9), 3224-3232.
[http://dx.doi.org/10.1097/00003246-200009000-00018] [PMID: 11008986]
[12]
Begieneman, M.P.; Kubat, B.; Ulrich, M.M.; Hahn, N.E.; Stumpf-Stolker, Y.; Tempelaars, M.; Middelkoop, E.; Zeerleder, S.; Wouters, D.; van Ham, M.S.; Niessen, H.W.; Krijnen, P.A. Prolonged C1 inhibitor administration improves local healing of burn wounds and reduces myocardial inflammation in a rat burn wound model. J. Burn Care Res., 2012, 33(4), 544-551.
[http://dx.doi.org/10.1097/BCR.0b013e31823bc2fc] [PMID: 22447201]
[13]
Farkas, H.; Varga, L. Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency. Biol. Ther., 2012, 2(1), 2.
[http://dx.doi.org/10.1007/s13554-012-0002-5] [PMID: 24490128]
[14]
Korkmaz, H.I.; Ulrich, M.M.W.; van Wieringen, W.N.; Vlig, M.; Emmens, R.W.; Meyer, K.W.; Sinnige, P.; Krijnen, P.A.J.; van Zuijlen, P.P.M.; Niessen, H.W.M. The local and systemic inflammatory iesponse in a pig burn wound model with a pivotal role for complement. J. Burn Care Res., 2017, 38(5), e796-e806.
[http://dx.doi.org/10.1097/BCR.0000000000000486] [PMID: 28447971]
[15]
Hoekstra, M.J.; Hupkens, P.; Dutrieux, R.P.; Bosch, M.M.; Brans, T.A.; Kreis, R.W. A comparative burn wound model in the New Yorkshire pig for the histopathological evaluation of local therapeutic regimens: Silver sulfadiazine cream as a standard. Br. J. Plast. Surg., 1993, 46(7), 585-589.
[http://dx.doi.org/10.1016/0007-1226(93)90111-N] [PMID: 8252267]
[16]
Middelkoop, E.; van den Bogaerdt, A.J.; Lamme, E.N.; Hoekstra, M.J.; Brandsma, K.; Ulrich, M.M. Porcine wound models for skin substitution and burn treatment. Biomaterials, 2004, 25(9), 1559-1567.
[http://dx.doi.org/10.1016/S0142-9612(03)00502-7] [PMID: 14697858]
[17]
Castellani, R.J.; Mojica, G.; Perry, G. The role of the iron stain in assessing intracranial hemorrhage. Open Neurol. J., 2016, 10, 136-142.
[http://dx.doi.org/10.2174/1874205X01610010136] [PMID: 27857815]
[18]
Team, R.D.C. R: A language and environment for statistical computing; R Foundation for Statistical Computing: Vienna, Austria,. , 2016.
[19]
Giraudox, P. Pgirmess: Data Analysis in Ecology., R package,. 2016.
[20]
Siegel, S.C.N.J. Non parametric statistics for the behavioural sciences; MacGraw Hill Int: New York, 1988.
[21]
Igonin, A.A.; Protsenko, D.N.; Galstyan, G.M.; Vlasenko, A.V.; Khachatryan, N.N.; Nekhaev, I.V.; Shlyapnikov, S.A.; Lazareva, N.B.; Herscu, P. C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Crit. Care Med., 2012, 40(3), 770-777.
[http://dx.doi.org/10.1097/CCM.0b013e318236edb8] [PMID: 22080632]
[22]
Vo, A.A.; Zeevi, A.; Choi, J.; Cisneros, K.; Toyoda, M.; Kahwaji, J.; Peng, A.; Villicana, R.; Puliyanda, D.; Reinsmoen, N.; Haas, M.; Jordan, S.C. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation, 2015, 99(2), 299-308.
[http://dx.doi.org/10.1097/TP.0000000000000592] [PMID: 25606785]
[23]
Markiewski, M.M.; Lambris, J.D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol., 2007, 171(3), 715-727.
[http://dx.doi.org/10.2353/ajpath.2007.070166] [PMID: 17640961]
[24]
Shashidharamurthy, R.; Hennigar, R.A.; Fuchs, S.; Palaniswami, P.; Sherman, M.; Selvaraj, P. Extravasations and emigration of neutrophils to the inflammatory site depend on the interaction of immune-complex with Fcgamma receptors and can be effectively blocked by decoy Fcgamma receptors. Blood, 2008, 111(2), 894-904.
[http://dx.doi.org/10.1182/blood-2007-04-085944] [PMID: 17962513]
[25]
Shupp, J.W.; Nasabzadeh, T.J.; Rosenthal, D.S.; Jordan, M.H.; Fidler, P.; Jeng, J.C. A review of the local pathophysiologic bases of burn wound progression. J. Burn Care Res., 2010, 31(6), 849-873.
[http://dx.doi.org/10.1097/BCR.0b013e3181f93571] [PMID: 21105319]
[26]
Zeerleder, S.; Caliezi, C.; van Mierlo, G.; Eerenberg-Belmer, A.; Sulzer, I.; Hack, C.E.; Wuillemin, W.A. Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis. Clin. Diagn. Lab. Immunol., 2003, 10(4), 529-535.
[http://dx.doi.org/10.1128/CDLI.10.4.529-535.2003] [PMID: 12853381]
[27]
Salvesen, B.; Nielsen, E.W.; Harboe, M.; Saugstad, O.D.; Mollnes, T.E. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood. Mol. Immunol., 2009, 46(4), 688-694.
[http://dx.doi.org/10.1016/j.molimm.2008.09.001] [PMID: 18950866]
[28]
Thorgersen, E.B.; Ludviksen, J.K.; Lambris, J.D.; Sfyroera, G.; Nielsen, E.W.; Mollnes, T.E. Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity. Innate Immun., 2010, 16(4), 254-264.
[http://dx.doi.org/10.1177/1753425909340420] [PMID: 19710096]
[29]
Wouters, D.; Wagenaar-Bos, I.; van Ham, M.; Zeerleder, S. C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin. Biol. Ther., 2008, 8(8), 1225-1240.
[http://dx.doi.org/10.1517/14712598.8.8.1225] [PMID: 18613773]
[30]
Loffredo, S.; Bova, M.; Suffritti, C.; Borriello, F.; Zanichelli, A.; Petraroli, A.; Varricchi, G.; Triggiani, M.; Cicardi, M.; Marone, G. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema. Allergy, 2016, 71(7), 989-996.
[http://dx.doi.org/10.1111/all.12862] [PMID: 26873113]
[31]
Henry Li, H.; Riedl, M.; Kashkin, J.; Ward, P.A. Update on the use of C1-esterase inhibitor replacement therapy in the acute and prophylactic treatment of hereditary angioedema. Clin. Rev. Allergy Immunol., 2019, 56(2), 207-218.
[http://dx.doi.org/10.1007/s12016-018-8684-1] [PMID: 29909591]
[32]
Mulligan, M.S.; Yeh, C.G.; Rudolph, A.R.; Ward, P.A. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J. Immunol., 1992, 148(5), 1479-1485.
[PMID: 1311349]

Rights & Permissions Print Cite
Article Metrics
39
2
© 2024 Bentham Science Publishers | Privacy Policy